封面
市场调查报告书
商品编码
1663034

癌症资讯系统市场规模、份额和成长分析(按产品/服务、应用、最终用户和地区)- 产业预测 2025-2032

Oncology Information Systems Market Size, Share, and Growth Analysis, By Product and Service (Software, Professional Services), By Application (Radiation Oncology, Medical Oncology), By End User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023 年全球癌症资讯系统市场规模价值 72.1 亿美元,预计将从 2024 年的 77.8 亿美元成长到 2032 年的 142.9 亿美元,预测期内(2025-2032 年)的复合年增长率为 7.9%。

癌症资讯系统 (OIS) 对医院、诊所和实验室至关重要,它促进组织间的资料交换,以优化癌症治疗并提高护理品质和病人安全。随着政府对癌症研究和开发的资助不断增加,对有效的患者资讯和资料管理解决方案的需求也日益增长,OIS 市场有望经历显着增长。需求的激增促使对各种 OIS 软体包的投资以及创新技术的开发,尤其是在肿瘤学领域。此外,OIS 还透过全面的资料为临床医生提供支持,以便及时、精准地进行治疗并评估治疗结果。随着医疗保健预算的扩大,投资 OIS 开发商提供了一个有利可图的机会,以满足对先进医疗规划系统日益增长的需求。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 次要和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024 年)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 监管分析
  • 技术分析
  • 专利分析

癌症资讯系统市场规模(依产品/服务)

  • 市场概况
  • 软体
    • 病人资讯系统
    • 放射科资讯系统
    • 肿瘤电子健康纪录 (EHR)
    • 实验室资讯系统
    • 化疗资讯系统
    • 治疗计划系统
    • 临床决策支援系统
    • 放射治疗计划系统
    • 近距离放射治疗计划系统
    • 治疗管理系统及医学影像分析系统
    • 人口健康管理
    • 临床整合解决方案
    • 影像存檔和通讯系统 (PACS) 和 VNA
    • 高级视觉化和影像分析解决方案
    • 辐射剂量管理解决方案
  • 专业服务
    • 咨询/优化服务
    • 实施服务
    • 售后及维修服务

癌症资讯系统市场规模(按应用)

  • 市场概况
  • 放射肿瘤学
  • 肿瘤内科
  • 外科肿瘤学

癌症资讯系统市场规模(按最终用户划分)

  • 市场概况
  • 医院和诊断影像中心
  • 消融治疗中心和癌症治疗中心
  • 政府
  • 研究设施

癌症资讯系统市场规模

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲国家
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前 5 家公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采用的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024 年)
  • 主要企业简介
    • 公司详细信息
    • 产品系列分析
    • 公司分部份额分析
    • 收益与前一年同期比较对比(2022-2024 年)

主要企业简介

  • Elekta AB(Sweden)
  • McKesson Corporation(United States)
  • Siemens Healthineers(Germany)
  • Epic Systems Corporation(United States)
  • IBM Corporation(United States)
  • Cerner Corporation(United States)
  • Advanced Data Systems Corporation(United States)
  • F. Hoffmann-La Roche AG(Switzerland)
  • AmerisourceBergen Corporation(United States)
  • General Electric Company(United States)
  • Accuray Incorporated(United States)
  • Optum, Inc.(United States)
  • Allscripts Healthcare Solutions, Inc.(United States)
  • MICA Information Systems, Inc.(United States)
  • CureMD Healthcare(United States)
  • EndoSoft LLC(United States)
  • RaySearch Laboratories AB(Sweden)
  • Altos Solutions(United States)
  • Flatiron Health(United States)
  • Bogardus Medical Systems(United States)

结论和建议

简介目录
Product Code: SQMIG35A2458

Global Oncology Information Systems Market size was valued at USD 7.21 billion in 2023 and is poised to grow from USD 7.78 billion in 2024 to USD 14.29 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

Oncology Information Systems (OIS) are becoming crucial for hospitals, clinics, and research labs by optimizing cancer care and facilitating inter-organizational data exchange to enhance treatment quality and patient safety. With growing government funding for oncology research and development, the OIS market is poised for significant growth, driven by the increasing need for effective patient information and data management solutions. This surge in demand is prompting investments in diverse OIS software packages and the development of innovative technologies, particularly in the cancer sector. Additionally, OIS ensures timely and accurate treatment delivery, supporting clinicians with comprehensive data for evaluating treatment outcomes. As healthcare budgets expand, investing in leading OIS developers presents lucrative opportunities to meet the evolving demand for advanced medical planning systems.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Information Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oncology Information Systems Market Segments Analysis

Global Oncology Information Systems Market is segmented by Product and Service, Application, End User and region. Based on Product and Service, the market is segmented into Software and Professional Services. Based on Application, the market is segmented into Radiation Oncology, Medical Oncology and Surgical Oncology. Based on End User, the market is segmented into Hospitals & Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions and Research Facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oncology Information Systems Market

The growing prevalence of cancer worldwide significantly propels the global oncology information systems market. The World Health Organization (WHO) highlights that cancer ranks among the foremost causes of mortality globally, underscoring the need for efficient treatment planning, data management, and patient care strategies. Oncology information systems enhance the functionality of oncology departments by enabling real-time information sharing, thereby increasing the precision of treatments. This improved accuracy not only optimizes patient outcomes but is also supported by advancements in pharmaceutical therapies. As such, the urgent demand for innovative solutions in cancer care continues to drive the market expansion for oncology information systems.

Restraints in the Global Oncology Information Systems Market

A significant challenge hindering the global adoption of Oncology Information Systems (OIS) is the substantial cost involved in their implementation and ongoing maintenance. Advanced OIS platforms necessitate considerable investments in infrastructure, software, and highly trained personnel, which can be a financial strain for smaller healthcare facilities, particularly in low- and middle-income countries. Additionally, the continuous need for maintenance, software updates, and robust cybersecurity measures further compounds these expenses, restricting the growth potential of the market in regions with limited resources. The high financial barrier poses a considerable restraint to the widespread acceptance and utilization of OIS in various healthcare environments.

Market Trends of the Global Oncology Information Systems Market

The global oncology information systems (OIS) market is witnessing a significant trend with the integration of artificial intelligence (AI) to enhance treatment accuracy and operational efficiency. AI-powered OIS can analyze extensive patient data, identify patterns, and forecast treatment outcomes, leading to more personalized and effective care. This technological advancement minimizes human error and accelerates decision-making, particularly in complex oncology cases. As demand for advanced cancer care grows, companies are heavily investing in AI capabilities to differentiate their offerings and gain a competitive edge in the market, driving the adoption of innovative solutions in oncology management worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Analysis
  • Technology Analysis
  • Patent Analysis

Global Oncology Information Systems Market Size by Product and Service & CAGR (2025-2032)

  • Market Overview
  • Software
    • Patient Information Systems
    • Radiology Information Systems
    • Oncology Electronic Medical Record (EHR)
    • Laboratory Information Systems
    • Chemotherapy Information System
    • Treatment Planning Systems
    • Clinical Decision Support Systems
    • Radiotherapy Treatment Planning Systems
    • Brachytherapy Treatment Planning Systems
    • Treatment Management Systems & Medical Image Analysis Systems
    • Population Health Management
    • Clinical Integration Solutions
    • Picture Archiving and Communication System (PACS) & VNA
    • Advanced Visualization & Image Analysis Solutions
    • Radiation Dose Management Solutions
  • Professional Services
    • Consulting/Optimization Services
    • Implementation Services
    • Post-Sale and Maintenance Services

Global Oncology Information Systems Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology

Global Oncology Information Systems Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals & Diagnostic Imaging Centers
  • Ablation Care Centers and Cancer Care Centers
  • Government Institutions
  • Research Facilities

Global Oncology Information Systems Market Size & CAGR (2025-2032)

  • North America (Product and Service, Application, End User)
    • US
    • Canada
  • Europe (Product and Service, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product and Service, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product and Service, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product and Service, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Elekta AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • McKesson Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Epic Systems Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IBM Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerner Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Data Systems Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AmerisourceBergen Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • General Electric Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accuray Incorporated (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Optum, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allscripts Healthcare Solutions, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MICA Information Systems, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CureMD Healthcare (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EndoSoft LLC (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RaySearch Laboratories AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Altos Solutions (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Flatiron Health (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bogardus Medical Systems (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations